Funding for motor neurone disease (MND) research has received a boost through a unique fundraising initiative involving vintage trucks. Dr. Lotta Oikari, a senior research officer at QIMR Berghofer ...
Biogen’s applications for the higher dose regimen of spinal muscular atrophy (SMA) drug Spinraza are now under review in the US and Europe.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback